Related Experiment Video
Updated: Jun 21, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors
Gemma Navarro1, Marisol S Aymerich2, Daniel Marcellino3
1Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, and Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
Calmodulin (CaM) binds to adenosine A(2A) and dopamine D(2) receptor heteromers. Calcium ions induce conformational changes, modulating signaling pathways relevant to basal ganglia disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Calmodulin (CaM) is a Ca(2+)-binding protein known to interact with G protein-coupled receptors (GPCRs).
- CaM binds to the cytoplasmic domains of receptors like the dopamine D(2) receptor, influencing its interactions.
- Adenosine A(2A) and dopamine D(2) receptors form heteromers implicated in neurological disorders.
Purpose of the Study:
- To investigate the binding of CaM to the adenosine A(2A) receptor.
- To explore the oligomerization of CaM with A(2A)-D(2) receptor heteromers.
- To determine the effect of Ca(2+) on CaM-A(2A)-D(2) receptor complex conformation and signaling.
Main Methods:
- Proteomics and bioluminescence resonance energy transfer (BRET) techniques were employed.
- BRET and sequential resonance energy transfer were used to study receptor oligomerization.
- BRET competition experiments assessed CaM binding sites within the heteromer.
Main Results:
- Evidence was found for CaM binding to the A(2A) receptor.
- CaM, A(2A), and D(2) receptors form oligomers, with CaM binding to a C-terminal epitope on A(2A) receptors.
- Ca(2+) induced conformational changes in the CaM-A(2A)-D(2) oligomer.
- Ca(2+) selectively modulated A(2A) and D(2) receptor-mediated MAPK signaling.
Conclusions:
- CaM interacts with A(2A)-D(2) receptor heteromers.
- Ca(2+) plays a role in regulating the structure and function of these heteromers.
- These findings offer insights into potential therapeutic targets for basal ganglia disorders like Parkinson's disease.
More Related Videos
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis